(Q74187550)

English

Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers

scientific article published on 01 June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

L E Janocko

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K A Brown

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C A Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L P Gu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A A Pollice

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S G Singh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Julian

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

N Wolmark

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L Sweeney

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J F Silverman

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S E Shackney

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

number of pages

14

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

136-149

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

describes a project that uses

fluorescence in situ hybridization

1 reference

based on heuristic

inferred from title

Genetic instabilities in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Genetic instability in colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Immunohistochemical studies of early breast cancer evolution

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Evolution of neoplastic cell lineages in Barrett oesophagus

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Discrepancies between flow cytometric and cytogenetic studies in the detection of aneuploidy in human solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

The significance of oncogene amplification in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast Tumors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Cyclin D1 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

The p53 tumor suppressor gene in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Mdm2 promotes the rapid degradation of p53

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Regulation of p53 stability by Mdm2

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

A p53-dependent mouse spindle checkpoint

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

The G(2) checkpoint is maintained by redundant pathways

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Abnormal centrosome amplification in the absence of p53.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Genomic instability in MycER-activated Rat1A-MycER cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

C-myc overexpression and p53 loss cooperate to promote genomic instability

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Cyclin D1 protein expression and function in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

Oncogene organisation and expression: prediction in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

21 January 2018

The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.1098

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CYTO.1098

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11449404%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74187550&oldid=2105810980"